Statistics
Publications
26
Citations
1.3K
H-Index
18
Active since
1991
Xingping Qin is an author at Harvard University specializing in oncology, medicine, and life sciences.
Publications per year
1991–2025
26
26
Targeting TBK1 to overcome resistance to cancer immunotherapy
Yi Sun, Or‐Yam Revach, Seth Anderson et al. · Nature · 2023 · 167 citations · Full text
Medicine, Cancer Biology, Oncology +12
AI is a viable alternative to high throughput screening: a 318-target study
Izhar Wallach, Denzil Bernard, Kong T. Nguyen et al. · Scientific Reports · 2024 · 120 citations · Full text
Rui Liu, Xinyu Liao, Meng‐Xian Pan et al. · The Journal of Immunology · 2019 · 110 citations
1–5 of 26